{"organizations": [], "uuid": "49e492d41e144b2de1cc5e963f75d814c7c25e4a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/09/22/idUSFWN11R01920150922", "country": "US", "title": "BRIEF-PledPharma key compound patent for Pledox and Aaladote set to gain US approval", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "BRIEF-PledPharma key compound patent for Pledox and Aaladote set to gain US approval | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-09-22T11:02:00.000+03:00", "replies_count": 0, "uuid": "49e492d41e144b2de1cc5e963f75d814c7c25e4a"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/09/22/idUSFWN11R01920150922", "ord_in_thread": 0, "title": "BRIEF-PledPharma key compound patent for Pledox and Aaladote set to gain US approval", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Sept 22 Pledpharma publ AB :\n* PledPharma reports that the United States Patent and Trademark Office (USPTO) has announced a \"Notice of Allowance\" for PledPharma's patent for the active ingredient of the drug candidates PledOx and Aladote\n* A Notice of Allowance means that the USPTO intends to grant the application\n* Patent term extends to Dec. 2032 Source text for Eikon:\nFurther company coverage: (Gdynia Newsroom)", "external_links": [], "published": "2015-09-22T11:02:00.000+03:00", "crawled": "2015-09-22T10:25:29.146+03:00", "highlightTitle": ""}